lucrin
abbvie limited - leuprorelin acetate 5 mg/ml - solution for injection - 5 mg/ml - active: leuprorelin acetate 5 mg/ml excipient: benzyl alcohol glacial acetic acid sodium chloride sodium hydroxide water for injection - lucrin (leuprorelin acetate) is indicated · in metastatic prostate cancer · in locally advanced prostate cancer, as an alternative to surgical castration · as an adjuvant treatment to radiotherapy in patients with high-risk localized or locally advanced prostate cancer · as an adjuvant treatment to radical prostatectomy in patients with locally advanced prostate cancer at high risk of disease progression
leuprex 3, 5mg implant
rowex ltd - leuprorelin acetate - implant - 3 mg, 5 milligram(s) - gonadotropin releasing hormone analogues; leuprorelin
lucrin depot 3
abbvie pty ltd - leuprorelin acetate, quantity: 22.5 mg - injection, modified release - excipient ingredients: mannitol; polylactic acid - in the palliative treatment of metastatic or locally extensive prostatic cancer. (stage c and d).
lucrin depot 7.5mg powder for injection prefilled dual-chamber syringe with 23 g needle
abbvie pty ltd - leuprorelin acetate, quantity: 7.5 mg - injection, modified release - excipient ingredients: gelatin; mannitol; polyglactin - lucrin depot 7.5 mg injection and lucrin depot 3 month 22.5mg injection and lucrin depot 4 month 30mg injection are indicated in the palliative treatment of metastatic or locally extensive prostatic cancer (stage c and d).
prostap 3 dcs 11.25 mg powder and solvent for prolonged-release suspension for injection in pre-filled syringe
takeda products ireland ltd - leuprorelin acetate - powder and solvent for prolonged-release suspension for injection in pre-filled syringe - 11.25 milligram(s) - gonadotropin releasing hormone analogues; leuprorelin
prostap 6 dcs 30 mg powder and solvent for prolonged-release suspension for injection in pre-filled syringe
takeda products ireland ltd - leuprorelin acetate - powder and solvent for prolonged-release suspension for injection in pre-filled syringe - 30 milligram(s) - gonadotropin releasing hormone analogues; leuprorelin
prostap sr dcs 3.75 mg powder and solvent for prolonged-release suspension for injection in pre-filled syringe
takeda products ireland ltd - leuprorelin acetate - powder and solvent for prolonged-release suspension for injection in pre-filled syringe - 3.75 milligram(s) - gonadotropin releasing hormone analogues; leuprorelin
lutrate 1 month depot 3.75 mg powder and solvent for prolonged-release suspension for injection
gp-pharm, s.a. - leuprorelin acetate - powder and solvent for prolonged-release suspension for injection - 3.75 milligram(s) - gonadotropin releasing hormone analogues; leuprorelin
eligard 22.5 mg powder and solvent for solution for injection
recordati industria chimica e farmaceutica spa - leuprorelin acetate - powder and solvent for solution for injection - 22.5 milligram(s) - gonadotropin releasing hormone analogues; leuprorelin
eligard 45 mg powder and solvent for solution for injection
recordati industria chimica e farmaceutica spa - leuprorelin acetate - powder and solvent for solution for injection - 45 milligram(s) - gonadotropin releasing hormone analogues; leuprorelin